Drug Profile
Research programme: urokinase plasminogen activator inhibitors - Heidelberg Pharma AG
Alternative Names: uPA inhibitors - Heidelberg Pharma; WX 508; WX 678; WX 77X series; WX-340Latest Information Update: 20 Nov 2017
Price :
$50
*
At a glance
- Originator Wilex
- Developer WILEX AG
- Class Small molecules
- Mechanism of Action Urokinase-type plasminogen activator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Solid tumours